Skip to main content

Language: English / Gàidhlig

Loading…

Seòmar agus comataidhean

Questions and answers

Parliamentary questions can be asked by any MSP to the Scottish Government or the Scottish Parliamentary Corporate Body. The questions provide a means for MSPs to get factual and statistical information.

  • Written questions must be answered within 10 working days (20 working days during recess)
  • Other questions such as Topical, Portfolio, General and First Minister's Question Times are taken in the Chamber

Urgent Questions aren't included in the Question and Answers search.  There is a SPICe fact sheet listing Urgent and emergency questions.

Find out more about parliamentary questions

Criathragan Hide all filters

Dates of parliamentary sessions
  1. Session 1: 12 May 1999 to 31 March 2003
  2. Session 2: 7 May 2003 to 2 April 2007
  3. Session 3: 9 May 2007 to 22 March 2011
  4. Session 4: 11 May 2011 to 23 March 2016
  5. Session 5: 12 May 2016 to 5 May 2021
  6. Current session: 12 May 2021 to 17 January 2025
Answer status
Question type

Displaying 1604 questions Show Answers

|

Question reference: S6W-05025

  • Asked by: Claire Baker, MSP for Mid Scotland and Fife, Scottish Labour
  • Date lodged: Tuesday, 14 December 2021
  • Current Status: Answered by Angela Constance on 11 January 2022

To ask the Scottish Government by what date the public health surveillance system, referenced in the Scottish Drug Deaths Taskforce’s Interim Report, will be fully operational, and what information the system will collate.

Question reference: S6W-05028

  • Asked by: Claire Baker, MSP for Mid Scotland and Fife, Scottish Labour
  • Date lodged: Tuesday, 14 December 2021
  • Current Status: Answered by Angela Constance on 11 January 2022

To ask the Scottish Government for what reason it has not established a drug checking service, such as WEDINOS, which was launched by NHS Wales in 2013, and whether it has any plans to establish a similar service in the future.

Question reference: S6W-05023

  • Asked by: Claire Baker, MSP for Mid Scotland and Fife, Scottish Labour
  • Date lodged: Tuesday, 14 December 2021
  • Current Status: Answered by Angela Constance on 11 January 2022

To ask the Scottish Government, in light of the National Patient Safety Alert issued by Public Health England, Potent synthetic opioids implicated in increase in drug overdoses, which was issued on 18 August 2021, whether it has been notified of any instances of (a) isotonitazene and (b) other synthetic opioids having been detected in the illegal drugs market in Scotland, and, if so, (i) when and (ii) where each instance occurred.

Question reference: S6W-05022

  • Asked by: Claire Baker, MSP for Mid Scotland and Fife, Scottish Labour
  • Date lodged: Tuesday, 14 December 2021
  • Current Status: Answered by Angela Constance on 11 January 2022

To ask the Scottish Government, further to the comments by the Minister for Drugs Policy on 17 June 2021 about Public Health Scotland’s ongoing surveillance work (Official Report, c.57), how many people (a) have died and (b) were admitted to hospital in connection with the consumption of (i) isotonitazene and (ii) other synthetic opioids in 2021, broken down by NHS board.

Question reference: S6W-05104

  • Asked by: Claire Baker, MSP for Mid Scotland and Fife, Scottish Labour
  • Date lodged: Monday, 13 December 2021
  • Current Status: Answered by Angela Constance on 10 January 2022

To ask the Scottish Government how many of the drug-related deaths that were included in the National Records for Scotland (NRS) Homeless Deaths reports for 2017-2020, were also included in the drug-related deaths figures that were published by the NRS in each year between 2017 and 2020.

Question reference: S6O-00572

  • Asked by: Claire Baker, MSP for Mid Scotland and Fife, Scottish Labour
  • Date lodged: Wednesday, 15 December 2021
  • Current Status: Taken in the Chamber on 22 December 2021

To ask the Scottish Government what progress it has made on its commitment to increase the number of employee-owned businesses in Scotland to 500 by 2030.

Question reference: S6O-00547

  • Asked by: Claire Baker, MSP for Mid Scotland and Fife, Scottish Labour
  • Date lodged: Wednesday, 08 December 2021
  • Current Status: Taken in the Chamber on 16 December 2021

To ask the Scottish Government how it is engaging with, and investing in, the live performance sector to support its recovery.

Question reference: S6W-04220

  • Asked by: Claire Baker, MSP for Mid Scotland and Fife, Scottish Labour
  • Date lodged: Tuesday, 09 November 2021
  • Current Status: Answered by Angela Constance on 23 November 2021

To ask the Scottish Government, further to the statement by the Minister for Drugs Policy on 26 October regarding holistic support for families (Official Report, c. 69), how much of the £3.5 million of funding for the current financial year has been allocated to each alcohol and drug partnership to support the mental health and wellbeing of family members affected by drug use.

Question reference: S6W-04219

  • Asked by: Claire Baker, MSP for Mid Scotland and Fife, Scottish Labour
  • Date lodged: Tuesday, 09 November 2021
  • Current Status: Answered by Angela Constance on 23 November 2021

To ask the Scottish Government what the projected cost is of the national marketing campaign to reduce the stigmatisation of people with a drug problem; how long it will run for; whether it is being targeted to particular locations, and how it is being funded.

Question reference: S6W-04218

  • Asked by: Claire Baker, MSP for Mid Scotland and Fife, Scottish Labour
  • Date lodged: Tuesday, 09 November 2021
  • Current Status: Answered by Angela Constance on 23 November 2021

To ask the Scottish Government, further to the statement by the Minister for Drugs Policy on 26 October 2021 that there will be a "rapid review of the services that are required to support people who experience mental health and substance use problems" (Official Report, c. 69), who will carry out the review; whether it will provide further details of the review’s remit, and when it anticipates (a) the review will be completed and (b) a report will be published.